With generics looming, Pfizer wins FDA nod for longer-acting Lyrica by Eric Sagonowsky Thursday, October 12, 2017 Bracing for generic competition to big-selling Lyrica, Pfizer has won FDA approval for a longer-lasting version that could help it defend sales.
